Title : Effect of combination therapy with alogliptin and lansoprazole on glycemic control in patients with type 2 diabetes.

Pub. Date : 2014

PMID : 25185672






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 The main purpose of the current study was to investigate the effect of a combination of alogliptin [a dipeptydil peptidase (DPP)-4 inhibitor] and lansoprazole [a proton pump inhibitor (PPI)] compared with alogliptin mono-therapy on glycemic control in patients with type 2 diabetes. alogliptin dipeptidyl peptidase 4 Homo sapiens